A High-Throughput Drug Screen Reveals Means to Differentiate Triple-Negative Breast Cancer

Using a high-throughput imaging-based reporter drug screen with 9501 compounds, investigators identified three polo-like kinase 1 inhibitors as major inducers of estrogen receptor α protein expression and downstream activity in TNBC cells.